Abstract Search

ea0037gp.28.03 | Endocrine tumours and neoplasia – NETS | ECE2015

Could ^99mTc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?

Hubalewska-Dydejczyk Alicja , Sowa-Staszczak Anna , Stefanska Agnieszka , Pach Dorota , Buziak-Bereza Monika , Trofimiuk-Muldner Malgorzata , Gilis-Januszewska Aleksandra , Jabrocka-Hybel Agata , Tomaszuk Monika , Tomaszewska Romana , Malecki Maciej , Bednarczuk Tomasz , Kaminski Grzegorz , Kowalska Aldona , Mikolajczak Renata , Janota Barbara

Surgery is the only effective therapy for insulinoma patients, therefore there is a necessity to develop diagnostic strategies in cases of unknown tumour location, possibly through the use of new biomarkers. 99mTc labelled glucagon-like peptide 1 analogue (99mTc-GLP1) scintigraphy has been developed in our centre as an imaging technique of insulinoma. Labelled GLP1 analogue might also be applied in diagnosis of various forms of nesidioblastosis allowing t...

0 shares

ePoster

Endocrine Abstracts

Could ^99mTc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?

BiosciAbstracts

Endocrine Abstracts

Could 99mTc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?

BiosciAbstracts

Could ^99mTc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?